# EDGAR Filing Document

**Accession Number:** 0001965754
**File Stem:** 0001578563-23-000006
**Filing Date:** 2023-2
**Character Count:** 9824
**Document Hash:** fa72c716c99821a62dab56626591258b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001578563-23-000006.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0001578563-23-000006

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20220608

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BAYER AKTIENGESELLSCHAFT
- **CENTRAL INDEX KEY:** 0001144145
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40440
- **FILM NUMBER:** 23619197

**BUSINESS ADDRESS:**
- **STREET 1:** BAYERWERK, GEBAEUDE W11
- **STREET 2:** KAISER-WILHELM-ALLEE
- **CITY:** LEVERKUSEN
- **STATE:** 2M
- **ZIP:** D-51368
- **BUSINESS PHONE:** 492143081933

**MAIL ADDRESS:**
- **STREET 1:** BAYERWERK, GEBAEUDE W11
- **STREET 2:** KAISER-WILHELM-ALLEE
- **CITY:** LEVERKUSEN
- **STATE:** 2M
- **ZIP:** D-51368
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BAYER HEALTHCARE LLC
- **CENTRAL INDEX KEY:** 0001231517
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40440
- **FILM NUMBER:** 23619200

**BUSINESS ADDRESS:**
- **STREET 1:** 511 BENEDICT AVE.
- **CITY:** TARRYTOWN
- **STATE:** NY
- **ZIP:** 10591-5097
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Bayer US Holding LP
- **CENTRAL INDEX KEY:** 0001965754
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40440
- **FILM NUMBER:** 23619199

**BUSINESS ADDRESS:**
- **STREET 1:** 100 BAYER BOULEVARD
- **CITY:** WHIPPANY
- **STATE:** NJ
- **ZIP:** 07981
- **BUSINESS PHONE:** (862) 404-3000

**MAIL ADDRESS:**
- **STREET 1:** 100 BAYER BOULEVARD
- **CITY:** WHIPPANY
- **STATE:** NJ
- **ZIP:** 07981
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Bayer World Investments B.V.
- **CENTRAL INDEX KEY:** 0001820027

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40440
- **FILM NUMBER:** 23619198

**BUSINESS ADDRESS:**
- **STREET 1:** ENERGIEWEG 1
- **CITY:** MIJDRECHT
- **STATE:** P7
- **ZIP:** 3641
- **BUSINESS PHONE:** 00 31 297 280 666

**MAIL ADDRESS:**
- **STREET 1:** ENERGIEWEG 1
- **CITY:** MIJDRECHT
- **STATE:** P7
- **ZIP:** 3641
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Senti Biosciences, Inc.
- **CENTRAL INDEX KEY:** 0001854270
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 862437900
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2 CORPORATE DRIVE, FIRST FLOOR
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** (650) 382-3281

**MAIL ADDRESS:**
- **STREET 1:** 2 CORPORATE DRIVE, FIRST FLOOR
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Senti Biosciences, Inc.\
- **DATE OF NAME CHANGE:** 20220615

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dynamics Special Purpose Corp.
- **DATE OF NAME CHANGE:** 20210331

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BAYER HEALTHCARE LLC<br><sub>(Last) (First) (Middle)</sub><br>100 BAYER BOULEVARD<br><sub>(Street)</sub><br>WHIPPANY, NJ 07981<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Senti Biosciences, Inc. [ SNTI ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2022-06-08 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Bayer US Holding LP<br><sub>(Last) (First) (Middle)</sub><br>100 BAYER BOULEVARD<br><sub>(Street)</sub><br>WHIPPANY, NJ 07981<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Senti Biosciences, Inc. [ SNTI ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2022-06-08 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Bayer World Investments B.V.<br><sub>(Last) (First) (Middle)</sub><br>SIRIUSDREEF 36<br><sub>(Street)</sub><br>HOOFDDORP, P7 2132WT<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Senti Biosciences, Inc. [ SNTI ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2022-06-08 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BAYER AKTIENGESELLSCHAFT<br><sub>(Last) (First) (Middle)</sub><br>BAYERWERK, GEBAEUDE W11<br>KAISER-WILHELM-ALLEE 1<br><sub>(Street)</sub><br>LEVERKUSEN, 2M 51373<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Senti Biosciences, Inc. [ SNTI ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2022-06-08 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 5878488 | D<sup>(1)</sup> |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is controlled by Bayer US Holding LP ("BUSH LP"), a Delaware limited partnership. Bayer World Investments B.V. ("BWI"), a Dutch private limited company, is the general partner of BUSH LP. BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC.

**Signature:** Bayer HealthCare LLC, By: /s/ Keith R. Abrams, Name: Keith R. Abrams, Title: Assistant Secretary  
**Date:** 2023-02-13

**Signature:** Bayer US Holding LP, By: /s/ Keith R. Abrams, Name: Keith R. Abrams, Title: Assistant Secretary  
**Date:** 2023-02-13

**Signature:** Bayer World Investments B.V., By: /s/ Patrick Lennaerts, Name: Patrick Lennaerts, Title: Managing Director  
**Date:** 2023-02-13

**Signature:** Bayer Aktiengesellschaft, By: /s/ Deny-Jean Silny, Name: Deny-Jean Silny, Title: Legal Head Mergers & Acquisitions  
**Date:** 2023-02-13

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**